Cargando…
The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
(1) Background: Multiple myeloma is a rare cancer that primarily affects the bone marrow. Osteoclasts are responsible for increased bone resorption and, therefore, bone destruction. Bisphosphonates are a class of drugs that can slow down bone resorption by reducing the number and action of osteoclas...
Autores principales: | Bacci, Christian, Cerrato, Alessia, Dotto, Virginia, Zambello, Renato, Barilà, Gregorio, Liço, Albana, Semenzato, Gianpietro, Stellini, Edoardo, Zanette, Gastone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908966/ https://www.ncbi.nlm.nih.gov/pubmed/33498207 http://dx.doi.org/10.3390/dj9020011 |
Ejemplares similares
-
Bisphosphonate-related osteonecrosis of the jaws (Bronj)
por: Beninati, Francesco, et al.
Publicado: (2013) -
Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016) -
Development of animal model for Bisphosphonates-related osteonecrosis of the jaw (BRONJ)
por: Jang, Hyo-Won, et al.
Publicado: (2015) -
Novel insight into the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ)()
por: Kishimoto, Hiromitsu, et al.
Publicado: (2019) -
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
por: Petcu, Eugen B, et al.
Publicado: (2012)